These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27871021)

  • 21. Occult hepatitis B virus infection: influence of S protein variants.
    Zhang Z; Zhang L; Dai Y; Zhang Y; Li J; Li X
    Virol J; 2016 Jan; 13():10. PubMed ID: 26786229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
    Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
    Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
    Luo YY; Tao Y; Cai XF; Zhang WL; Long QX; Guo H; Huang AL; Hu JL
    Antiviral Res; 2016 Feb; 126():99-107. PubMed ID: 26738784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains.
    Herbers U; Amini-Bavil-Olyaee S; Mueller A; Luedde T; Trautwein C; Tacke F
    J Viral Hepat; 2013 Feb; 20(2):141-8. PubMed ID: 23301549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
    Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
    Lin M; Yang LY; Li WY; Peng YP; Zheng JK
    J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-naïve and lamivudine-treated patients with chronic hepatitis B.
    Ding H; Liu B; Zhao C; Yang J; Yan C; Yan L; Zhuang H; Li T
    Antiviral Res; 2014 Feb; 102():29-34. PubMed ID: 24316031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological characteristics comparison of HBV rtA181T mutants with truncated or substituted HBsAg expression in vitro and in vivo model systems.
    Zhou LY; Chen EQ; Wang ML; Chen LL; Liu CP; Zeng F; Tang H
    Sci Rep; 2016 Dec; 6():39260. PubMed ID: 27976732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
    Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
    World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
    Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
    J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The truncated mutant HBsAg expression increases the tumorigenesis of hepatitis B virus by regulating TGF-β/Smad signaling pathway.
    Wang ML; Wu DB; Tao YC; Chen LL; Liu CP; Chen EQ; Tang H
    Virol J; 2018 Apr; 15(1):61. PubMed ID: 29609638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B antivirals and resistance.
    Devi U; Locarnini S
    Curr Opin Virol; 2013 Oct; 3(5):495-500. PubMed ID: 24016777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
    Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
    Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive selection signals of hepatitis B virus and their association with disease stages and viral genotypes.
    Xu Z; Wu G; Li F; Bai J; Xing W; Zhang D; Zeng C
    Infect Genet Evol; 2013 Oct; 19():176-87. PubMed ID: 23871771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral resistance mutations potentiate HBV surface antigen-induced transcription of hfgl2 prothrombinase gene.
    Li W; Han M; Li Y; Chen D; Luo X; Ning Q
    Biochemistry (Mosc); 2011 Sep; 76(9):1043-50. PubMed ID: 22082274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
    Sloan RD; Ijaz S; Moore PL; Harrison TJ; Teo CG; Tedder RS
    Antivir Ther; 2008; 13(3):439-47. PubMed ID: 18572757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
    Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
    Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.